nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—melanoma	0.426	1	CbGaD
Tolvaptan—CYP3A4—Temozolomide—melanoma	0.111	0.376	CbGbCtD
Tolvaptan—ABCB1—Dactinomycin—melanoma	0.0673	0.229	CbGbCtD
Tolvaptan—CYP3A4—Vemurafenib—melanoma	0.0606	0.206	CbGbCtD
Tolvaptan—ABCB1—Docetaxel—melanoma	0.0347	0.118	CbGbCtD
Tolvaptan—CYP3A4—Docetaxel—melanoma	0.0208	0.0707	CbGbCtD
Tolvaptan—Rash generalised—Vemurafenib—melanoma	0.0071	0.0592	CcSEcCtD
Tolvaptan—Colitis ischaemic—Docetaxel—melanoma	0.00349	0.0291	CcSEcCtD
Tolvaptan—Disseminated intravascular coagulation—Docetaxel—melanoma	0.00287	0.024	CcSEcCtD
Tolvaptan—Deep vein thrombosis—Temozolomide—melanoma	0.00253	0.0211	CcSEcCtD
Tolvaptan—Rash generalised—Docetaxel—melanoma	0.00241	0.0201	CcSEcCtD
Tolvaptan—Prurigo—Docetaxel—melanoma	0.00222	0.0185	CcSEcCtD
Tolvaptan—Vaginal haemorrhage—Temozolomide—melanoma	0.00208	0.0174	CcSEcCtD
Tolvaptan—Deep vein thrombosis—Docetaxel—melanoma	0.00169	0.0141	CcSEcCtD
Tolvaptan—Pulmonary embolism—Carmustine—melanoma	0.0016	0.0133	CcSEcCtD
Tolvaptan—Respiratory failure—Temozolomide—melanoma	0.00157	0.0131	CcSEcCtD
Tolvaptan—Pulmonary embolism—Temozolomide—melanoma	0.00154	0.0129	CcSEcCtD
Tolvaptan—Connective tissue disorder—Vemurafenib—melanoma	0.00149	0.0124	CcSEcCtD
Tolvaptan—Cardiac disorder—Vemurafenib—melanoma	0.00141	0.0117	CcSEcCtD
Tolvaptan—Angiopathy—Vemurafenib—melanoma	0.00137	0.0115	CcSEcCtD
Tolvaptan—Mediastinal disorder—Vemurafenib—melanoma	0.00137	0.0114	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Bleomycin—melanoma	0.00135	0.0113	CcSEcCtD
Tolvaptan—Malnutrition—Vemurafenib—melanoma	0.00132	0.011	CcSEcCtD
Tolvaptan—Dysgeusia—Vemurafenib—melanoma	0.00129	0.0108	CcSEcCtD
Tolvaptan—Thirst—Temozolomide—melanoma	0.00118	0.00981	CcSEcCtD
Tolvaptan—Hyponatraemia—Carmustine—melanoma	0.00116	0.0097	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00116	0.00966	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00112	0.0093	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00111	0.0093	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Docetaxel—melanoma	0.00108	0.00904	CcSEcCtD
Tolvaptan—Anaphylactic shock—Vemurafenib—melanoma	0.00108	0.00898	CcSEcCtD
Tolvaptan—Nervous system disorder—Vemurafenib—melanoma	0.00106	0.00881	CcSEcCtD
Tolvaptan—Skin disorder—Vemurafenib—melanoma	0.00105	0.00872	CcSEcCtD
Tolvaptan—Respiratory failure—Docetaxel—melanoma	0.00104	0.00871	CcSEcCtD
Tolvaptan—Dehydration—Temozolomide—melanoma	0.00104	0.00868	CcSEcCtD
Tolvaptan—Pulmonary embolism—Docetaxel—melanoma	0.00103	0.00855	CcSEcCtD
Tolvaptan—Breast disorder—Temozolomide—melanoma	0.00101	0.00844	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00101	0.00841	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Temozolomide—melanoma	0.000987	0.00824	CcSEcCtD
Tolvaptan—Decreased appetite—Vemurafenib—melanoma	0.000936	0.00781	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Vemurafenib—melanoma	0.000929	0.00775	CcSEcCtD
Tolvaptan—Constipation—Vemurafenib—melanoma	0.000921	0.00768	CcSEcCtD
Tolvaptan—Hyperglycaemia—Carmustine—melanoma	0.000903	0.00753	CcSEcCtD
Tolvaptan—Pollakiuria—Temozolomide—melanoma	0.000894	0.00746	CcSEcCtD
Tolvaptan—Renal failure—Carmustine—melanoma	0.000877	0.00732	CcSEcCtD
Tolvaptan—Hyperglycaemia—Temozolomide—melanoma	0.000873	0.00728	CcSEcCtD
Tolvaptan—Body temperature increased—Vemurafenib—melanoma	0.000851	0.0071	CcSEcCtD
Tolvaptan—Hypersensitivity—Vemurafenib—melanoma	0.000793	0.00662	CcSEcCtD
Tolvaptan—Connective tissue disorder—Carmustine—melanoma	0.000787	0.00657	CcSEcCtD
Tolvaptan—Renal impairment—Docetaxel—melanoma	0.000782	0.00652	CcSEcCtD
Tolvaptan—Asthenia—Vemurafenib—melanoma	0.000772	0.00644	CcSEcCtD
Tolvaptan—Urinary tract disorder—Temozolomide—melanoma	0.000765	0.00638	CcSEcCtD
Tolvaptan—Pruritus—Vemurafenib—melanoma	0.000762	0.00635	CcSEcCtD
Tolvaptan—Connective tissue disorder—Temozolomide—melanoma	0.000761	0.00635	CcSEcCtD
Tolvaptan—Urethral disorder—Temozolomide—melanoma	0.000759	0.00633	CcSEcCtD
Tolvaptan—Hyponatraemia—Docetaxel—melanoma	0.000747	0.00623	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000744	0.00621	CcSEcCtD
Tolvaptan—Ill-defined disorder—Bleomycin—melanoma	0.000741	0.00619	CcSEcCtD
Tolvaptan—Diarrhoea—Vemurafenib—melanoma	0.000737	0.00614	CcSEcCtD
Tolvaptan—Malaise—Bleomycin—melanoma	0.000721	0.00601	CcSEcCtD
Tolvaptan—Cardiac disorder—Temozolomide—melanoma	0.000719	0.006	CcSEcCtD
Tolvaptan—Dizziness—Vemurafenib—melanoma	0.000712	0.00594	CcSEcCtD
Tolvaptan—Angiopathy—Temozolomide—melanoma	0.000703	0.00586	CcSEcCtD
Tolvaptan—Immune system disorder—Temozolomide—melanoma	0.000699	0.00583	CcSEcCtD
Tolvaptan—Mediastinal disorder—Temozolomide—melanoma	0.000698	0.00582	CcSEcCtD
Tolvaptan—Malnutrition—Carmustine—melanoma	0.000698	0.00582	CcSEcCtD
Tolvaptan—Dehydration—Docetaxel—melanoma	0.000692	0.00577	CcSEcCtD
Tolvaptan—Ill-defined disorder—Dactinomycin—melanoma	0.000691	0.00577	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Docetaxel—melanoma	0.00068	0.00567	CcSEcCtD
Tolvaptan—Headache—Vemurafenib—melanoma	0.000674	0.00563	CcSEcCtD
Tolvaptan—Malnutrition—Temozolomide—melanoma	0.000674	0.00562	CcSEcCtD
Tolvaptan—Breast disorder—Docetaxel—melanoma	0.000673	0.00561	CcSEcCtD
Tolvaptan—Discomfort—Bleomycin—melanoma	0.000672	0.00561	CcSEcCtD
Tolvaptan—Malaise—Dactinomycin—melanoma	0.000672	0.00561	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00067	0.00559	CcSEcCtD
Tolvaptan—Dysgeusia—Temozolomide—melanoma	0.00066	0.00551	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Docetaxel—melanoma	0.000657	0.00548	CcSEcCtD
Tolvaptan—Anaphylactic shock—Bleomycin—melanoma	0.000652	0.00544	CcSEcCtD
Tolvaptan—Nausea—Vemurafenib—melanoma	0.000639	0.00533	CcSEcCtD
Tolvaptan—Discomfort—Dactinomycin—melanoma	0.000627	0.00523	CcSEcCtD
Tolvaptan—Ill-defined disorder—Temozolomide—melanoma	0.000625	0.00522	CcSEcCtD
Tolvaptan—Anorexia—Bleomycin—melanoma	0.000622	0.00519	CcSEcCtD
Tolvaptan—Malaise—Temozolomide—melanoma	0.000608	0.00507	CcSEcCtD
Tolvaptan—Anorexia—Dactinomycin—melanoma	0.00058	0.00484	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00057	0.00475	CcSEcCtD
Tolvaptan—Discomfort—Temozolomide—melanoma	0.000567	0.00473	CcSEcCtD
Tolvaptan—Decreased appetite—Bleomycin—melanoma	0.000567	0.00473	CcSEcCtD
Tolvaptan—Renal failure—Docetaxel—melanoma	0.000564	0.0047	CcSEcCtD
Tolvaptan—Dry mouth—Temozolomide—melanoma	0.000561	0.00468	CcSEcCtD
Tolvaptan—Anaphylactic shock—Temozolomide—melanoma	0.00055	0.00459	CcSEcCtD
Tolvaptan—Anorexia—Carmustine—melanoma	0.000543	0.00453	CcSEcCtD
Tolvaptan—Nervous system disorder—Temozolomide—melanoma	0.00054	0.0045	CcSEcCtD
Tolvaptan—Feeling abnormal—Bleomycin—melanoma	0.000537	0.00448	CcSEcCtD
Tolvaptan—Skin disorder—Temozolomide—melanoma	0.000534	0.00446	CcSEcCtD
Tolvaptan—Decreased appetite—Dactinomycin—melanoma	0.000529	0.00441	CcSEcCtD
Tolvaptan—Anorexia—Temozolomide—melanoma	0.000524	0.00437	CcSEcCtD
Tolvaptan—Body temperature increased—Bleomycin—melanoma	0.000516	0.0043	CcSEcCtD
Tolvaptan—Urinary tract disorder—Docetaxel—melanoma	0.000509	0.00424	CcSEcCtD
Tolvaptan—Connective tissue disorder—Docetaxel—melanoma	0.000506	0.00422	CcSEcCtD
Tolvaptan—Urethral disorder—Docetaxel—melanoma	0.000505	0.00421	CcSEcCtD
Tolvaptan—Feeling abnormal—Dactinomycin—melanoma	0.000501	0.00418	CcSEcCtD
Tolvaptan—Decreased appetite—Carmustine—melanoma	0.000495	0.00413	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Carmustine—melanoma	0.000491	0.0041	CcSEcCtD
Tolvaptan—Constipation—Carmustine—melanoma	0.000487	0.00406	CcSEcCtD
Tolvaptan—Body temperature increased—Dactinomycin—melanoma	0.000481	0.00401	CcSEcCtD
Tolvaptan—Hypersensitivity—Bleomycin—melanoma	0.00048	0.00401	CcSEcCtD
Tolvaptan—Decreased appetite—Temozolomide—melanoma	0.000478	0.00399	CcSEcCtD
Tolvaptan—Cardiac disorder—Docetaxel—melanoma	0.000478	0.00399	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Temozolomide—melanoma	0.000475	0.00396	CcSEcCtD
Tolvaptan—Constipation—Temozolomide—melanoma	0.00047	0.00392	CcSEcCtD
Tolvaptan—Feeling abnormal—Carmustine—melanoma	0.000469	0.00391	CcSEcCtD
Tolvaptan—Asthenia—Bleomycin—melanoma	0.000468	0.0039	CcSEcCtD
Tolvaptan—Angiopathy—Docetaxel—melanoma	0.000467	0.0039	CcSEcCtD
Tolvaptan—Immune system disorder—Docetaxel—melanoma	0.000465	0.00388	CcSEcCtD
Tolvaptan—Mediastinal disorder—Docetaxel—melanoma	0.000464	0.00387	CcSEcCtD
Tolvaptan—Pruritus—Bleomycin—melanoma	0.000461	0.00385	CcSEcCtD
Tolvaptan—Feeling abnormal—Temozolomide—melanoma	0.000453	0.00378	CcSEcCtD
Tolvaptan—Body temperature increased—Carmustine—melanoma	0.00045	0.00375	CcSEcCtD
Tolvaptan—Malnutrition—Docetaxel—melanoma	0.000448	0.00374	CcSEcCtD
Tolvaptan—Hypersensitivity—Dactinomycin—melanoma	0.000448	0.00374	CcSEcCtD
Tolvaptan—Dysgeusia—Docetaxel—melanoma	0.000439	0.00366	CcSEcCtD
Tolvaptan—Asthenia—Dactinomycin—melanoma	0.000436	0.00364	CcSEcCtD
Tolvaptan—Body temperature increased—Temozolomide—melanoma	0.000435	0.00363	CcSEcCtD
Tolvaptan—Hypersensitivity—Carmustine—melanoma	0.000419	0.0035	CcSEcCtD
Tolvaptan—Diarrhoea—Dactinomycin—melanoma	0.000416	0.00347	CcSEcCtD
Tolvaptan—Asthenia—Carmustine—melanoma	0.000408	0.00341	CcSEcCtD
Tolvaptan—Hypersensitivity—Temozolomide—melanoma	0.000405	0.00338	CcSEcCtD
Tolvaptan—Syncope—Docetaxel—melanoma	0.000402	0.00335	CcSEcCtD
Tolvaptan—Asthenia—Temozolomide—melanoma	0.000395	0.00329	CcSEcCtD
Tolvaptan—Loss of consciousness—Docetaxel—melanoma	0.000394	0.00329	CcSEcCtD
Tolvaptan—Diarrhoea—Carmustine—melanoma	0.00039	0.00325	CcSEcCtD
Tolvaptan—Pruritus—Temozolomide—melanoma	0.000389	0.00325	CcSEcCtD
Tolvaptan—Nausea—Bleomycin—melanoma	0.000387	0.00323	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000379	0.00316	CcSEcCtD
Tolvaptan—Dizziness—Carmustine—melanoma	0.000376	0.00314	CcSEcCtD
Tolvaptan—Diarrhoea—Temozolomide—melanoma	0.000376	0.00314	CcSEcCtD
Tolvaptan—Dry mouth—Docetaxel—melanoma	0.000373	0.00311	CcSEcCtD
Tolvaptan—Anaphylactic shock—Docetaxel—melanoma	0.000366	0.00305	CcSEcCtD
Tolvaptan—Dizziness—Temozolomide—melanoma	0.000364	0.00303	CcSEcCtD
Tolvaptan—Nausea—Dactinomycin—melanoma	0.000361	0.00301	CcSEcCtD
Tolvaptan—Shock—Docetaxel—melanoma	0.00036	0.003	CcSEcCtD
Tolvaptan—Nervous system disorder—Docetaxel—melanoma	0.000359	0.00299	CcSEcCtD
Tolvaptan—Headache—Carmustine—melanoma	0.000357	0.00298	CcSEcCtD
Tolvaptan—Skin disorder—Docetaxel—melanoma	0.000355	0.00296	CcSEcCtD
Tolvaptan—Anorexia—Docetaxel—melanoma	0.000349	0.00291	CcSEcCtD
Tolvaptan—Headache—Temozolomide—melanoma	0.000345	0.00288	CcSEcCtD
Tolvaptan—Nausea—Carmustine—melanoma	0.000338	0.00282	CcSEcCtD
Tolvaptan—Nausea—Temozolomide—melanoma	0.000327	0.00273	CcSEcCtD
Tolvaptan—Decreased appetite—Docetaxel—melanoma	0.000318	0.00265	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Docetaxel—melanoma	0.000316	0.00263	CcSEcCtD
Tolvaptan—Constipation—Docetaxel—melanoma	0.000313	0.00261	CcSEcCtD
Tolvaptan—Feeling abnormal—Docetaxel—melanoma	0.000301	0.00251	CcSEcCtD
Tolvaptan—Body temperature increased—Docetaxel—melanoma	0.000289	0.00241	CcSEcCtD
Tolvaptan—Hypersensitivity—Docetaxel—melanoma	0.00027	0.00225	CcSEcCtD
Tolvaptan—Asthenia—Docetaxel—melanoma	0.000262	0.00219	CcSEcCtD
Tolvaptan—Pruritus—Docetaxel—melanoma	0.000259	0.00216	CcSEcCtD
Tolvaptan—Vismodegib—ALB—melanoma	0.000255	0.512	CrCbGaD
Tolvaptan—Diarrhoea—Docetaxel—melanoma	0.00025	0.00209	CcSEcCtD
Tolvaptan—Vismodegib—ABCB1—melanoma	0.000243	0.488	CrCbGaD
Tolvaptan—Dizziness—Docetaxel—melanoma	0.000242	0.00202	CcSEcCtD
Tolvaptan—Headache—Docetaxel—melanoma	0.000229	0.00191	CcSEcCtD
Tolvaptan—Nausea—Docetaxel—melanoma	0.000217	0.00181	CcSEcCtD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	6.81e-05	0.000427	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	6.68e-05	0.000419	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ERBB4—melanoma	6.64e-05	0.000417	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CB—melanoma	6.62e-05	0.000416	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ERBB4—melanoma	6.59e-05	0.000414	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN2B—melanoma	6.58e-05	0.000413	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CB—melanoma	6.58e-05	0.000413	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN2B—melanoma	6.54e-05	0.00041	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CD86—melanoma	6.37e-05	0.0004	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP1B1—melanoma	6.37e-05	0.0004	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCL8—melanoma	6.37e-05	0.0004	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	6.34e-05	0.000398	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CD86—melanoma	6.32e-05	0.000397	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCL8—melanoma	6.32e-05	0.000397	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EDN1—melanoma	6.32e-05	0.000397	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—UGT2B10—melanoma	6.3e-05	0.000395	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	6.28e-05	0.000394	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EDN1—melanoma	6.27e-05	0.000394	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CSF2—melanoma	6.18e-05	0.000388	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGF1—melanoma	6.18e-05	0.000388	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGF1—melanoma	6.13e-05	0.000385	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CSF2—melanoma	6.13e-05	0.000385	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—IL2—melanoma	6.08e-05	0.000382	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—E2F1—melanoma	6.04e-05	0.000379	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—IL2—melanoma	6.04e-05	0.000379	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	6.02e-05	0.000378	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CB—melanoma	6.02e-05	0.000378	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—E2F1—melanoma	6e-05	0.000377	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	5.99e-05	0.000376	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PDGFRA—melanoma	5.98e-05	0.000375	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CB—melanoma	5.97e-05	0.000375	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PDGFRA—melanoma	5.94e-05	0.000373	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ITGB3—melanoma	5.92e-05	0.000372	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PRKCA—melanoma	5.92e-05	0.000372	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PRKCA—melanoma	5.88e-05	0.000369	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ITGB3—melanoma	5.88e-05	0.000369	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—melanoma	5.86e-05	0.000368	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HS3ST5—melanoma	5.86e-05	0.000368	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SPP1—melanoma	5.81e-05	0.000365	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAP2K2—melanoma	5.79e-05	0.000363	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL8—melanoma	5.78e-05	0.000363	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SPP1—melanoma	5.76e-05	0.000362	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAP2K2—melanoma	5.75e-05	0.000361	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL8—melanoma	5.74e-05	0.00036	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	5.64e-05	0.000354	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	5.57e-05	0.00035	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL2—melanoma	5.52e-05	0.000347	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TERT—melanoma	5.5e-05	0.000346	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RAC1—melanoma	5.49e-05	0.000345	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL2—melanoma	5.48e-05	0.000344	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TERT—melanoma	5.46e-05	0.000343	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RAC1—melanoma	5.45e-05	0.000342	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HIF1A—melanoma	5.26e-05	0.00033	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	5.25e-05	0.00033	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HIF1A—melanoma	5.23e-05	0.000328	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	5.16e-05	0.000324	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	5.04e-05	0.000316	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KDR—melanoma	5.03e-05	0.000316	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KDR—melanoma	5e-05	0.000314	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	4.99e-05	0.000313	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FN1—melanoma	4.85e-05	0.000304	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FN1—melanoma	4.81e-05	0.000302	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	4.75e-05	0.000298	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOTCH1—melanoma	4.74e-05	0.000298	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOTCH1—melanoma	4.71e-05	0.000296	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CD80—melanoma	4.65e-05	0.000292	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APC—melanoma	4.64e-05	0.000291	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CG—melanoma	4.64e-05	0.000291	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KIT—melanoma	4.64e-05	0.000291	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—NRAS—melanoma	4.64e-05	0.000291	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CD80—melanoma	4.61e-05	0.00029	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KIT—melanoma	4.6e-05	0.000289	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APC—melanoma	4.6e-05	0.000289	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CG—melanoma	4.6e-05	0.000289	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—NRAS—melanoma	4.6e-05	0.000289	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EGF—melanoma	4.58e-05	0.000288	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EGF—melanoma	4.55e-05	0.000286	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	4.51e-05	0.000283	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	4.44e-05	0.000279	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MAPK3—melanoma	4.44e-05	0.000279	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLCB4—melanoma	4.44e-05	0.000279	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MAPK3—melanoma	4.41e-05	0.000277	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	4.38e-05	0.000275	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—BRAF—melanoma	4.36e-05	0.000274	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—BRAF—melanoma	4.33e-05	0.000272	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	4.28e-05	0.000269	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF1—melanoma	4.25e-05	0.000267	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ACER3—melanoma	4.24e-05	0.000266	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MAPK1—melanoma	4.23e-05	0.000265	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—EGFR—melanoma	4.22e-05	0.000265	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF1—melanoma	4.22e-05	0.000265	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MAPK1—melanoma	4.2e-05	0.000263	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—EGFR—melanoma	4.19e-05	0.000263	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC6A11—melanoma	4.17e-05	0.000262	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIP4K2A—melanoma	4.17e-05	0.000262	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAP2K1—melanoma	4.1e-05	0.000258	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CD—melanoma	4.08e-05	0.000256	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAP2K1—melanoma	4.07e-05	0.000256	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	4.07e-05	0.000256	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTAP—melanoma	4.06e-05	0.000255	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	4.06e-05	0.000255	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CD—melanoma	4.05e-05	0.000254	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CA—melanoma	4.04e-05	0.000254	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CA—melanoma	4.01e-05	0.000252	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—KRAS—melanoma	3.99e-05	0.000251	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	3.97e-05	0.00025	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—KRAS—melanoma	3.96e-05	0.000249	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGF2—melanoma	3.9e-05	0.000245	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—UGT2B10—melanoma	3.88e-05	0.000244	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGF2—melanoma	3.88e-05	0.000243	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	3.87e-05	0.000243	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	3.83e-05	0.000241	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	3.74e-05	0.000235	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	3.73e-05	0.000234	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	3.72e-05	0.000233	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CA—melanoma	3.67e-05	0.00023	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MDM2—melanoma	3.65e-05	0.000229	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CA—melanoma	3.64e-05	0.000229	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MDM2—melanoma	3.63e-05	0.000228	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LUM—melanoma	3.62e-05	0.000227	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PHGDH—melanoma	3.62e-05	0.000227	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HS3ST5—melanoma	3.61e-05	0.000227	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ERBB2—melanoma	3.6e-05	0.000226	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ERBB2—melanoma	3.57e-05	0.000224	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CB—melanoma	3.55e-05	0.000223	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HPSE—melanoma	3.55e-05	0.000223	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CB—melanoma	3.53e-05	0.000221	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CUBN—melanoma	3.48e-05	0.000219	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL8—melanoma	3.41e-05	0.000214	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HRAS—melanoma	3.39e-05	0.000213	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL8—melanoma	3.39e-05	0.000213	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	3.37e-05	0.000212	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HRAS—melanoma	3.37e-05	0.000211	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CSPG4—melanoma	3.36e-05	0.000211	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SDHD—melanoma	3.36e-05	0.000211	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—BSG—melanoma	3.36e-05	0.000211	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN1B—melanoma	3.33e-05	0.000209	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN1B—melanoma	3.31e-05	0.000208	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT1—melanoma	3.3e-05	0.000207	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT1—melanoma	3.27e-05	0.000206	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CASP3—melanoma	3.27e-05	0.000205	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2—melanoma	3.26e-05	0.000205	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GPAM—melanoma	3.26e-05	0.000205	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—melanoma	3.25e-05	0.000204	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CASP3—melanoma	3.24e-05	0.000204	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2—melanoma	3.24e-05	0.000203	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—melanoma	3.22e-05	0.000202	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.19e-05	0.0002	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCND1—melanoma	3.18e-05	0.0002	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCND1—melanoma	3.16e-05	0.000198	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CTNNB1—melanoma	3.15e-05	0.000198	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CTNNB1—melanoma	3.13e-05	0.000196	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.1e-05	0.000195	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—melanoma	3.09e-05	0.000194	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN1A—melanoma	3.08e-05	0.000193	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTEN—melanoma	3.07e-05	0.000193	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—melanoma	3.07e-05	0.000193	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NFKB1—melanoma	3.06e-05	0.000192	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN1A—melanoma	3.06e-05	0.000192	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTEN—melanoma	3.05e-05	0.000191	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.04e-05	0.000191	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.04e-05	0.000191	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NFKB1—melanoma	3.03e-05	0.00019	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT1—melanoma	3e-05	0.000188	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT1—melanoma	2.97e-05	0.000187	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	2.89e-05	0.000181	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	2.87e-05	0.00018	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—melanoma	2.77e-05	0.000174	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLA2G6—melanoma	2.77e-05	0.000174	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—melanoma	2.75e-05	0.000173	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STAT3—melanoma	2.75e-05	0.000172	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NRAS—melanoma	2.74e-05	0.000172	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLCB4—melanoma	2.73e-05	0.000172	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT3—melanoma	2.73e-05	0.000171	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NRAS—melanoma	2.72e-05	0.000171	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.63e-05	0.000165	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK3—melanoma	2.62e-05	0.000165	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK3—melanoma	2.6e-05	0.000164	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC6A11—melanoma	2.57e-05	0.000161	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIP4K2A—melanoma	2.57e-05	0.000161	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MYC—melanoma	2.55e-05	0.00016	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.55e-05	0.00016	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MYC—melanoma	2.53e-05	0.000159	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTAP—melanoma	2.5e-05	0.000157	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK1—melanoma	2.5e-05	0.000157	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EGFR—melanoma	2.5e-05	0.000157	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—VCAN—melanoma	2.49e-05	0.000156	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK1—melanoma	2.48e-05	0.000156	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EGFR—melanoma	2.48e-05	0.000156	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KRAS—melanoma	2.36e-05	0.000148	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KRAS—melanoma	2.34e-05	0.000147	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LUM—melanoma	2.23e-05	0.00014	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PHGDH—melanoma	2.23e-05	0.00014	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HPSE—melanoma	2.19e-05	0.000137	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CA—melanoma	2.17e-05	0.000136	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.15e-05	0.000135	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CA—melanoma	2.15e-05	0.000135	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CUBN—melanoma	2.15e-05	0.000135	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP17A1—melanoma	2.1e-05	0.000132	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—melanoma	2.1e-05	0.000132	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—melanoma	2.08e-05	0.000131	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SDHD—melanoma	2.07e-05	0.00013	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—BSG—melanoma	2.07e-05	0.00013	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CSPG4—melanoma	2.07e-05	0.00013	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GPAM—melanoma	2.01e-05	0.000126	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HRAS—melanoma	2e-05	0.000126	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HRAS—melanoma	1.99e-05	0.000125	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GNA11—melanoma	1.98e-05	0.000124	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.94e-05	0.000122	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—FASN—melanoma	1.94e-05	0.000122	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—melanoma	1.92e-05	0.00012	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC5A5—melanoma	1.91e-05	0.00012	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—melanoma	1.9e-05	0.00012	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GNAQ—melanoma	1.84e-05	0.000116	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CD44—melanoma	1.84e-05	0.000116	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT1—melanoma	1.77e-05	0.000111	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP1B1—melanoma	1.77e-05	0.000111	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT1—melanoma	1.76e-05	0.00011	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLA2G6—melanoma	1.71e-05	0.000107	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—VCAN—melanoma	1.53e-05	9.62e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PRKCA—melanoma	1.34e-05	8.41e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ERCC2—melanoma	1.33e-05	8.34e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP17A1—melanoma	1.29e-05	8.12e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GNA11—melanoma	1.22e-05	7.67e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FASN—melanoma	1.2e-05	7.5e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC5A5—melanoma	1.18e-05	7.38e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GNAQ—melanoma	1.14e-05	7.13e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CD44—melanoma	1.14e-05	7.13e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP1B1—melanoma	1.09e-05	6.83e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CG—melanoma	1.05e-05	6.59e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARG—melanoma	1.01e-05	6.36e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CD—melanoma	9.22e-06	5.79e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—melanoma	9.1e-06	5.71e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCB1—melanoma	8.96e-06	5.63e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PRKCA—melanoma	8.25e-06	5.18e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ERCC2—melanoma	8.18e-06	5.14e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CB—melanoma	8.04e-06	5.05e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—melanoma	7.96e-06	5e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTEN—melanoma	6.94e-06	4.36e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CG—melanoma	6.46e-06	4.06e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARG—melanoma	6.24e-06	3.92e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CD—melanoma	5.68e-06	3.57e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—melanoma	5.61e-06	3.52e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CB—melanoma	4.95e-06	3.11e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—melanoma	4.91e-06	3.08e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CA—melanoma	4.9e-06	3.08e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTEN—melanoma	4.28e-06	2.69e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKT1—melanoma	4e-06	2.51e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CA—melanoma	3.02e-06	1.9e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKT1—melanoma	2.47e-06	1.55e-05	CbGpPWpGaD
